Controversy has broken out in India regarding access to two treatments that are used to address drug resistant tuberculosis (TB). The medications, bedaquiline and delamanid are all but unavailable in India, with fewer than 1,000 DR-TB patients in India receiving bedaquiline and only 81 receive delamanid. This has led to calls for the issuing of … [Read more...] about TB ‘miracle cures’ and the issue of high expectations
A robotic takeover has long been thought of as the stuff of nightmares, from being a staple of science fiction doomsday scenarios to being warned of by sci-tech leaders such as Elon Musk as an outcome if artificial intelligence (AI) technology continues to grow. In contrast to these bleak predictions on the future of robotics, however, the … [Read more...] about Robotic takeover of healthcare on the horizon?
Children in Africa have shown a prevalence of up to 54 percent of HIV strains which display a resistance to one or more commonly used antiretroviral (ARV) drugs according to a study published in Clinical Infectious Diseases. Is this an indication that currently used medications may prove to be ineffective in years to come? Africa has seen a … [Read more...] about Drug resistant HIV and the potential to render current treatments inviable
The London Family Planning summit has reportedly documented $5 billion in pledges to aid family planning services in developing nations, however, will the policies of the Trump administration hinder these efforts? On Tuesday, July 11, World Population Day was observed, with a timely theme: “Family Planning: Empowering People, Developing … [Read more...] about Mexico City Policy: Putting the US at odds with the EU?
Creating a single new prescription drug is currently estimated to cost $2.6 billion dollars. This is a sum so vast that only a small number of companies can afford to even consider the possibility. It is also a figure which is overshadowed by one major factor: failure. A staggeringly small number of medications are ever successful. As few as … [Read more...] about Pharmaceutical research: the price of failure
Emily Oster teaches economics at Chicago (one of the world's best economic faculties). As an economist, she concluded that she had lots of skills that she could apply to being pregnant, "making good decisions--in business, and in life--requires two things: the right data, and the right way to weigh the pluses and minuses of a decision personally. … [Read more...] about When two economists decide to have a child #pregnancy
By Melanie Jenkins Well shwmae a chroeso! Hello and welcome from the heart of Wales's rolling hills and valleys! Hyderus Cyf. is located on the High St. in a small Welsh village – Cwmfelinfach – Valley of the Little Mill. The High St. is a hub of activity with its busy Post Office and market. We are also on the main road linking the valley with … [Read more...] about The Hyderus Chronicles: Take a quick office tour and meet our team!
Well shwmae a chroeso! Hello and welcome from the heart of Wales's rolling hills and valleys! This blog is something we have been thinking about for a while now, so we’re very happy to be inaugurating it today. This is a space for our very talented team members to share their thoughts and insights, and for you to stay updated about our projects … [Read more...] about The Hyderus Chronicles: Welcome to the Hyderus blog!